SCHEMBL26499309

SCHEMBL26499309

O=c1n(-c2ccc(Cl)cc2)cnn1CCCN1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.47
DRD2 P14416 2/20 0.46
DRD3 P35462 2/20 0.46
MCHR1 Q99705 1/20 0.43
HRH3 Q9Y5N1 10/20 0.43
TMEM97 Q5BJF2 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HRH1 P35367 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CACNA1C Q13936 1/20 0.41
SCN5A Q14524 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA1D P25100 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22349797 0.73 PPARD (0.48) KMT2AKDM4E
SCHEMBL11972931 0.71 ALDH1A1 (0.41) KCNH2DRD2DRD3MCHR1HRH3
SCHEMBL11637592 0.71 KDM4E (0.67) KCNH2DRD2DRD3HRH3TMEM97
Hydrochloric Acid SCHEMBL11637430 0.68 KDM4E (0.67) DRD2DRD3TMEM97KDM4ESLC6A2
SCHEMBL6940234 0.68 ALDH1A1 (0.43) DRD2KDM4EADRA2CHRH1HTR1A
SCHEMBL22349810 0.68 MAPT (0.64) MEN1KMT2ATDP1
SCHEMBL9243893 0.68 PPARD (0.42)
SCHEMBL6940926 0.68 HTR1A (0.45) DRD2MEN1KMT2AKDM4EADRA2C
Hydrochloric Acid SCHEMBL9693076 0.68 ALDH1A1 (0.42) DRD2KDM4EADRA2CHRH1HTR1A
SCHEMBL31548630 0.66 HTR1A (0.45) KCNH2MCHR1TDP1CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-10-12 US disclosed
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS RABL3, VAPA, VAPB KCNH2 4556/4885DRD2 3895/4885DRD3 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.